Applied DNA Sciences Inc (APDN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Applied DNA Sciences Inc (APDN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7845
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company’s products comprise DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DNA sequences, and identity markers, among others. Its supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, and mark, track, and convict criminals; and fiberTyping, a test of native cotton fiber DNA. The company serves government and military, security and asset marking, industrial parts, pharmaceuticals, cannabis, textiles and apparel, personal care, fertilizer, and printing and packaging industries. APDN is headquartered in Stony Brook, New York, the US.

Applied DNA Sciences Inc (APDN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Applied DNA Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Applied DNA Sciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Applied DNA Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Applied DNA Sciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Applied DNA Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Applied DNA Sciences Inc, Medical Equipment, Deal Details 11
Partnerships 11
Applied DNA Sciences Extends Contract with U.S. Defense Logistics Agency 11
Colorcon Enters into Licensing Agreement with Applied DNA Sciences 12
Equity Offering 13
Applied DNA Sciences to Raise USD4.8 Million in Private Placement of Shares 13
Applied DNA Sciences Raises USD12 Million in Public Offering of Shares and Warrants 14
Applied DNA Sciences Raises USD0.2 Million in Private Placement of Shares 16
Applied DNA Sciences Raises USD0.4 Million in Priavte Palcement of Shares 17
Debt Offering 18
Applied DNA Sciences Raises USD1.7 Million in Private Placement of Notes 18
Applied DNA Sciences Inc – Key Competitors 19
Applied DNA Sciences Inc – Key Employees 20
Applied DNA Sciences Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Sep 18, 2018: Applied DNA forms wholly owned subsidiary, LineaRx, to develop large-scale, PCR-produced DNA for biotherapeutics 22
Jan 23, 2018: Applied DNA Expands Internationally with New Central DNA Testing Laboratory in India 24
Financial Announcements 25
Aug 13, 2018: Applied DNA reports fiscal third quarter 2018 financial results 25
May 03, 2018: Applied DNA Reports Fiscal Second Quarter 2018 Financial Results 27
Feb 08, 2018: Applied DNA Reports Fiscal First Quarter 2018 Financial Results 29
Dec 15, 2017: Applied DNA Announces Selected Preliminary Unaudited Fiscal Fourth Quarter and Year End Results 30
Dec 15, 2017: APDN Announces Selected Preliminary Unaudited Fiscal 4th Quarter and Year End Results 32
Aug 10, 2017: Applied DNA Reports Fiscal Third Quarter 2017 Financial Results 34
May 11, 2017: Applied DNA Sciences Reports Fiscal Second Quarter 2017 Financial Results 37
Feb 09, 2017: Applied DNA Sciences Reports Fiscal First Quarter 2017 Financial Results 39
Corporate Communications 41
Oct 04, 2018: Applied DNA appoints industry veteran Wayne Buchen Vice President of strategic sales for textile vertical 41
Jan 23, 2018: Applied DNA Expands Internationally with New Central DNA Testing Laboratory in India 42
Jan 24, 2017: Applied DNA Sciences Appoints Former NYPD Commissioner Ray Kelly to Strategic Advisory Board 43
Jan 04, 2017: APDN Appoints Dr. Mehmood Khan to Company’s Strategic Advisory Board 44
Product News 45
Apr 10, 2018: Applied DNA to Debut Security Print Platform Solution Featuring Videojet 1860M CIJ Printer at INTERPHEX 2018 45
Feb 21, 2017: Applied DNA Sciences Expands Patent Portfolio with a Range of Advancements that Enable Company’s Continued Penetration of Core Business Verticals 46
Other Significant Developments 47
Aug 02, 2018: Applied DNA Sciences reaches new milestones in therapeutic contract research and contract manufacturing of linear DNA 47
Feb 26, 2018: ACG Signs MoU With Applied DNA Sciences to Enhance Capsule Authentication and Traceability Technology for Pharmaceutical and Nutraceutical Industry 48
Jan 25, 2018: Applied DNA Awarded Multi-Year Contract to Develop Molecular Tracking Systems for Legal Cannabis Worldwide 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Applied DNA Sciences Inc, Medical Equipment, Key Facts, 2017 2
Applied DNA Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Applied DNA Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Applied DNA Sciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Applied DNA Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Applied DNA Sciences Inc, Deals By Market, 2012 to YTD 2018 9
Applied DNA Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Applied DNA Sciences Extends Contract with U.S. Defense Logistics Agency 11
Colorcon Enters into Licensing Agreement with Applied DNA Sciences 12
Applied DNA Sciences to Raise USD4.8 Million in Private Placement of Shares 13
Applied DNA Sciences Raises USD12 Million in Public Offering of Shares and Warrants 14
Applied DNA Sciences Raises USD0.2 Million in Private Placement of Shares 16
Applied DNA Sciences Raises USD0.4 Million in Priavte Palcement of Shares 17
Applied DNA Sciences Raises USD1.7 Million in Private Placement of Notes 18
Applied DNA Sciences Inc, Key Competitors 19
Applied DNA Sciences Inc, Key Employees 20
Applied DNA Sciences Inc, Subsidiaries 21

List of Figures
Applied DNA Sciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Applied DNA Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Applied DNA Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Applied DNA Sciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Applied DNA Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Applied DNA Sciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Applied DNA Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Applied DNA Sciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Applied DNA Sciences Inc (APDN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HOV Services Ltd (HOVS):企業の財務・戦略的SWOT分析
    HOV Services Ltd (HOVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cimarex Energy Co (XEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Cimarex Energy Co (Cimarax) is an independent upstream oil and natural gas company. It carries out the exploration and production of crude oil, natural gas and natural gas liquids (NGLs). The company’s operations are concentrated in two main areas namely the Mid-Continent region consisting o …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Cohort plc:企業の戦略・SWOT・財務情報
    Cohort plc - Strategy, SWOT and Corporate Finance Report Summary Cohort plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Tethys Oil AB (TETY):企業の財務・戦略的SWOT分析
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds 2P reserves of 21.4 mmbo and has an oil production of barrels from Blocks in Sultanate of Oman. It also holds onshore explorati …
  • IMV Inc (IMV):製薬・医療:M&Aディール及び事業提携情報
    Summary IMV Inc (IMV), formerly Immunovaccine Inc, is a clinical-stage biopharmaceutical company that develops cancer immunotherapies and infectious disease vaccines. The company’s product candidates include DPX-Survivac, a T cell activating immunotherapy that identifies and disrupts cancer biology …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Egyptian Resorts Co
    Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report Summary Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CGN New Energy Holdings Co Ltd (1811):企業の財務・戦略的SWOT分析
    CGN New Energy Holdings Co Ltd (1811) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Fluor Corp (FLR):企業の財務・戦略的SWOT分析
    Fluor Corp (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • New World Development Co Ltd (17):企業の財務・戦略的SWOT分析
    New World Development Co Ltd (17) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Experian plc:企業の戦略・SWOT・財務分析
    Experian plc - Strategy, SWOT and Corporate Finance Report Summary Experian plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Targa Resources Partners LP (NGLS PR A)-エネルギー分野:企業M&A・提携分析
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. The company provides midstream natural gas and natural gas liquids (NGL) services. Targa Resources carries out the gathering, compressing, treating, processing and selling of natural gas, and storing, fraction …
  • Invivo Corp-医療機器分野:企業M&A・提携分析
    Summary Invivo Corp (Invivo), a subsidiary of Koninklijke Philips NV is a medical device company that designs, manufactures, and markets patient monitoring systems. The company offers products in various categories such as advanced visualization systems, breast imaging and biopsy solutions, neuro im …
  • Horizon Discovery Group Plc (HZD):企業の財務・戦略的SWOT分析
    Summary Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers se …
  • Suntory Beverage & Food Limited:企業の戦略・SWOT・財務分析
    Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report Summary Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Orascom Development Egypt Sae
    Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report Summary Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437)-製薬・医療分野:企業M&A・提携分析
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products comprise pharmaceutical drugs for treating nutrition disorders, cardiovascular diseases, cancer and musculoskeletal disorders. Its pipeline pro …
  • Lam Research Corp (LRCX):企業の財務・戦略的SWOT分析
    Lam Research Corp (LRCX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆